Conclusion
migraine, RS
MIGRAINE, PATHOPHYSIOLOGY
Erenumab modulates RS FC of networks involved in migraine pathophysiology. In line with clinical response, erenumab-induced brain RS FC changes tend to reverse when treatment is stopped.